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Symptoms of difficult defecation such as
straining, feeling of incomplete evacuation after
defecation, or digital facilitation are reported by
40–74% of patients referred with chronic consti-
pation to a specialised centre [1]. These symptoms
defining dyschezia are frequently associated with
failure to relax the pelvic floor during attempts to
defecate, best described as pelvic floor dyssynergia
[2].
Treatment of chronic constipation with die-
tary modification and aperients is relatively inef-
fective [3]. Biofeedback therapy is claimed to be
successful in 18–100% of patients referred for
chronic constipation [4]. The variability in success
rate may be explained by poorly defined inclusion
criteria, small series, different methods of biofeed-
back and short duration of follow-up. We are un-
aware of any series reporting long-term results
after biofeedback in patients complaining of
chronic constipation associated with pelvic floor
dyssynergia.
The aim of the present study was to describe
long-term satisfaction of patients diagnosed with
pelvic floor dyssynergia after biofeedback.
Background: Patients referred for chronic con-
stipation frequently report symptoms of straining,
feeling of incomplete evacuation, or the need to fa-
cilitate defecation digitally (dyschezia). When such
patients show manometric evidence of inappropri-
ate contraction or failure to relax the pelvic floor
muscles during attempts to defecate, they are diag-
nosed as having pelvic floor dyssynergia (Rome I). 
Aims: To evaluate long-term satisfaction of pa-
tients with pelvic floor dyssynergia after biofeed-
back.
Patients: Forty-one consecutive patients re-
ferred for chronic constipation at an outpatient
gastrointestinal unit and diagnosed as having
pelvic floor dyssynergia who completed a full
course of biofeedback.
Methods: Data have been collected using a stan-
dardised questionnaire. A questionnaire survey of
patients’ satisfaction rate and requirement of ape-
rients was undertaken.
Results: Mean age and symptom duration were
respectively 41 and 20 years. Half of patients re-
ported fewer than 3 bowel motions per week. Pa-
tients were treated with a mean of 5 biofeedback
sessions. At the end of the therapy pelvic floor
dyssynergia was alleviated in 85% of patients and
49% were able to stop all aperients. Satisfaction
was maintained at follow-up telephone interviews
undertaken after a mean period of 2 years, as
biofeedback was helpful for 79% of patients and
47% still abstained from intake of aperients.
Conclusions: Satisfaction after biofeedback is
high for patients referred for chronic constipation
and diagnosed with pelvic floor dyssynergia.
Biofeedback improves symptoms related to
dyschezia and reduces use of aperients.
Keywords: constipation; dyschezia; pelvic floor dyssyner-
gia; biofeedback; survey
Summary
Introduction
Methods
Patients
Our study cohort consists of all consecutive patients
referred for chronic constipation and diagnosed with
pelvic floor dyssynergia who completed a full course of
biofeedback in our unit from March 1, 1992 to January 31,
1997. The patients included fulfilled the Rome I criteria
for dyschezia and pelvic floor dyssynergia [2]. The diag-
nosis of dyschezia was based on the presence of straining,
152Original article S W I S S  M E D  W K LY 2 0 0 1 ; 1 3 1 : 1 5 2 – 1 5 6 ·  w w w. s m w. c h
Peer reviewed article
S W I S S  M E D  W K LY 2 0 0 1 ; 1 3 1 : 1 5 2 – 1 5 6 ·  w w w. s m w. c h 153
feeling of incomplete evacuation after defecation, or hav-
ing to facilitate defecation digitally by pressing in or
around the anus on at least 25% of bowel movements.
Pelvic floor dyssynergia was characterised by dyschezia as-
sociated with manometric evidence of inappropriate con-
traction or failure to relax the pelvic floor muscles during
attempts to defecate. During the study period 29 patients,
who were not included in this study, completed a full
course of biofeedback (12 dyschezia without pelvic floor
dyssynergia, 14 faecal incontinence, 2 anorectal pain, 1 un-
specified anorectal disorder).
Anorectal tests
Anorectal manometry was performed as previously
described [5]. Balloon distension was used to detect the
rectal sensory thresholds for the first detectable sensation,
the sensation of urgency to defecate, and the maximum
tolerable volume. Paradoxical contraction of the pelvic
floor muscles was considered on any sustained rise in anal
pressure during straining without consecutive relaxation
of the anal sphincter [6].
Biofeedback
Biofeedback was provided on a weekly outpatient
basis. Surface electrodes placed adjacent to the anal verge
permit the patient to watch the trace of pelvic floor mus-
cle activity at rest, during voluntary contraction and while
attempting to expel a rectal balloon. The patients were
taught to be conscious of a balloon distending the rectum,
to relax the pelvic floor, to improve recto-anal coordina-
tion without increasing pelvic floor muscle activity and to
strain efficiently by using a propulsive force through brac-
ing with the abdominal muscles. A single therapist (PC)
performed all the sessions. The patients were also advised
on normal defecatory behaviour and bowel habits. An at-
tempt was made to wean patients off laxatives, enemas, and
suppositories. The therapist and the patient agreed to end
the therapy when both were satisfied with the progress
made. At the end of the biofeedback an assessment took
place and the anorectal tests were repeated. An investiga-
tor (PJ, PW) who had not been the patients’ therapist un-
dertook a follow-up telephone interview. 
Data were collected using a standardised question-
naire based on Rome I [2]. To establish the possible ben-
efits and satisfaction with the therapy the patients were
asked whether they felt that biofeedback had helped them
to defecate and whether or not their constipation had im-
proved. Enquiry was made about current use of aperients
(laxatives, suppositories, and enemas).
Statistical analysis
Continuous data are presented as mean ± STDEV.
The study variables at referral, after biofeedback and at
follow-up telephone interview, were compared by means
of McNemar’s test for binary variables, and with Student’s
paired t-test for continuous variables. To determine what
characteristics may predict response to treatment, logistic
regression was performed on the efficacy of biofeedback,
as reported by the patients at the follow-up telephone in-
terview – “biofeedback helped me on the whole” or not –
including, as co-variables, patients’ characteristics, base-
line signs and symptoms. p <0.05 was considered statisti-
cally significant. 
Results
Forty-one consecutive patients (34 females)
received biofeedback therapy for pelvic floor
dyssynergia. The mean age was 41 ± 17 years and
the mean duration of constipation symptoms 20 ±
15 years.
Patients were treated on a weekly basis by an
average of 5.0 ± 2.1 sessions. They were all assessed
after the end of the biofeedback therapy. The fol-
low-up interview took place after a mean period of
2.0 ± 1.2 years. Three patients were lost to follow-
up despite repeated attempts to contact them.
Patient satisfaction, symptoms
and use of aperients
79% of patients (30/38) expressed overall sat-
isfaction with biofeedback in the long term. The
percentage of satisfied patients did not change
significantly from end-of-treatment assessment
(35/41 patients) to long-term follow-up (30/38, 
p = 0.10). After biofeedback only 37% of patients
complained of constipation and the effect was
maintained in 53% of the cohort at follow-up (p
<0.0001, when compared to referral time). Table 1
shows that the number of patients reporting fewer
than 3 bowel movements per week was reduced
both immediately after biofeedback and at follow-
up. Similarly, symptoms of dyschezia (need to
strain, feeling of incomplete evacuation, need to
digitate), abdominal pain and bloating were re-
ported less frequently after biofeedback and at fol-
low-up than at the time of referral (Figure 1).
All patients relied regularly or occasionally on
aperients at referral. Half were able to cease using
aperients after biofeedback and this was main-
tained at follow-up (Table 1).
at referral after biofeedback p value at follow-up p value
(n = 41) (n = 41) (n = 38)
Bowel frequency (<3/week) 27 (66%) 6 (15%) <0.0001 4 (11%) <0.0001
Dyschezia 41 (100%) 9 (22%) <0.0001 11 (29%) <0.0001
Abdominal pain or bloating 21 (51%) 9 (22%) <0.0005 15 (39%) <0.0001
Use of aperients 41 (100%) 20 (51%) <0.0001 18 (53%) <0.03
Values are given as number of patients (percentage). Comparisons between periods are evaluated 
by McNemar’s test.
Table 1
Occurrence of symp-
toms and use of
aperients at referral,
after biofeedback and
at follow-up.
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Factors associated with patient satisfaction
Due to the high proportion of females (83%),
gender could not be analysed as a predictive factor
of outcome. Patients who were helped by biofeed-
back were not significantly younger than patients
who did not benefit from it (40 ± 17 vs. 45 ± 17
years). No symptom at initial assessment appeared
predictive of patients’ satisfaction (data not
shown). 
Patients helped by biofeedback received a
mean of 4 sessions, while those not improved re-
ceived a mean of 5 sessions (not statistically signif-
icant). Twenty patients were practising biofeed-
back exercises at the time of follow-up. However,
failure to practise home exercises was not signifi-
cantly associated with a failed outcome at long-
term follow-up.
Anorectal tests
Anorectal tests were performed on all patients.
Consistent with the Rome I criteria, all patients
showed manometric evidence of inappropriate
contraction or failure to relax the pelvic floor mus-
cles during attempts to defecate at referral time. At
the end of the biofeedback therapy physiological
relaxation of the pelvic floor during attempts to
defecate was more prevalent (Table 2). 
Mean values obtained for the cohort for max-
imum resting pressure, maximum squeeze pres-
sure, first sensation, urge sensation and maximum
tolerable volume-to-volume distension were all in
the normal range for our laboratory, both at refer-
ral and after biofeedback, without any significant
trend from initial to end-of-treatment assessment
[5]. However, urge sensation to volume distension
was lower after biofeedback compared with before
(Table 2). 
Correction of the inappropriate contraction of
the pelvic floor muscles at the end of biofeedback
sessions was not predictive of a satisfying outcome
at long-term follow-up. Twenty-six of the thirty
patients (87%) who felt that biofeedback had
helped them in the long term had previous mano-
metric correction of pelvic floor dysfunction im-
mediately after biofeedback, whereas 7 of 8 pa-
tients (88%) to whom biofeedback had not been
helpful had the same manometric resolution after
biofeedback. None of the anorectal tests was pre-
dictive of the outcome (data not shown).
Figure 1
Occurrence of
dyschezic symptoms
at referral, after
biofeedback and at
follow-up. Dyschezia
diagnosis is based on
Rome I criteria:
straining, feeling of
incomplete evacua-
tion after defecation,
or having to facilitate
defecation digitally
by pressing in or
around the anus [2].
Values are given as
percentages of pa-
tients at referral 
(41 patients), after
biofeedback (41 pa-
tients) and at follow-
up (38 patients).
Comparisons be-
tween periods are
evaluated by 
McNemar’s test.
Discussion
This study has shown that the majority of pa-
tients referred to a specialised centre for chronic
constipation related to pelvic floor dyssynergia are
satisfied with biofeedback in the long term. Im-
provement was supported by an increase in bowel
frequency and decreased use of aperients at long-
term follow-up.
Our cohort of middle-aged patients with a life-
long history of constipation is representative of the
population referred to specialised centres [7]. Nei-
ther patient age or duration of symptoms was in-
dicative of outcome [8, 9].
We restricted our entry criteria to patients ful-
filling Rome I criteria for pelvic floor dyssynergia
[2]. Patients had symptoms of dyschezia (straining,
feeling of incomplete evacuation after defecation,
or having to facilitate defecation digitally by press-
ing in or around the anus on at least 25% of bowel
movements) and manometric evidence of para-
doxical contraction or failure to relax the pelvic
floor muscles when attempting to defecate. With
these selection criteria 79% of our patients were
on the whole satisfied in the long term with
biofeedback. Symptoms of straining, feeling of in-
complete evacuation, need for digitation, abdom-
inal pain and bloating were all improved after
biofeedback. Despite the subjective nature of the
outcome variables, the improvement was sup-
ported by an increase in bowel frequency and a re-
duction in the use of aperients. Lower success rates
at referral after biofeedback p value
Inappropriate contraction pelvic floor 41 (100%) 6 (15%) <0.0001
Maximum resting pressure (mm Hg) 60 ± 18 57 ± 17 ns
Maximum squeeze pressure (mm Hg) 99 ± 36 103 ± 39 ns
First sensation to volume distension (ml) 19 ± 12 17 ± 16 ns
Urge sensation to volume distension (ml) 112 ± 56 85 ± 26 <0.003
Maximum tolerable volume (ml) 247 ± 88 252 ± 60 ns
Values are given as number of patients (percentage) and mean ± STDEV. Comparison is evaluated 
by McNemar’s test and Student’s paired t-test.
Table 2.
Anorectal tests 
at referral and after
biofeedback.
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have been described when entry criteria were
broadened [9–14]. The present study has shown
that clear-cut clinical criteria and anorectal
manometry render possible the selection of pa-
tients likely to benefit from biofeedback in the
long-term, without the costs and risk (i.e. high-
dose irradiation of defecography) of other tests.
Manometry was used to identify patients with
pelvic floor dysfunction. The majority of patients
had corrected this anomaly at the end of the
biofeedback sessions but long-term satisfaction did
not correlate with this finding. Rectal sensory per-
ception was improved after biofeedback and lower
thresholds for urge sensation to rectal distension
were measured, confirming previous observations
[10, 15–17]. The anorectal laboratory is an “ab-
normal” setting where patients are embarrassed
[18]. Conflicting results have been reported, with
some authors assigning predictive value to pre-
treatment investigations [19] and others not [20].
Slight but clinically significant physiological vari-
ations are difficult to record. Moreover, improve-
ments measured by anorectal tests do not neces-
sarily reflect symptomatic improvement, and
many patients may show physiological improve-
ment while functional improvement may lag be-
hind or vice versa. Anorectal testing is necessary to
diagnose pelvic floor dyssynergia and for the pa-
tient’s comprehension of anorectal physiology. It
allows the therapist to work on recto-anal coordi-
nation and rectal sensory perception to improve
the patient’s defecatory function.
Methods of biofeedback therapy varied widely
between centres [21] but no difference was de-
scribed when EMG-based biofeedback was com-
pared to manometry-based biofeedback [22], or
when visual or auditory feedback was given [10]. In
our study, as in others [11;23;24], the majority of
patients requested a limited number of biofeed-
back sessions. Weekly one-hour biofeedback ses-
sions allow focused remoulding of defecatory
habits over a short period of time. This gives pa-
tients access to a therapist who can devote time and
energy to providing counselling and training. Vi-
sual and verbal feedback based on surface EMG
electrodes was convenient both to the patient and
to the therapist.
Our high success rate may be due to the fact
that all of our patients ended the therapy only by
common consent with the therapist. Motivation 
of patients to complete the treatment [11, 14] 
and psychological factors influence response to
biofeedback [13, 25]. We believe that the patient’s
willingness to cure his/her defecatory disorder is
an important factor in therapeutic success. 
In conclusion, this study has shown a high de-
gree of satisfaction with biofeedback in patients
suffering from pelvic floor dyssynergia as a cause
of chronic constipation. The high rate and sus-
tained benefit at long-term follow-up argues
against a placebo response in patients who have
previously tried many remedies unsuccessfully.
Until a better therapy emerges biofeedback re-
mains a morbidity-free, low-cost and effective out-
patient therapy for well-motivated patients com-
plaining of constipation and diagnosed with pelvic
floor dyssynergia.
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